Grail's Slump Enters Week: Navigating Biotech's Setback
Grail's stock has slid as its Galleri MCED test faced a major trial setback. This piece breaks down what happened, wh...
Index funds and ETFs offer low-cost, diversified exposure to the market. This intro explains how they differ and when each might suit your investing goals.
28,655 articlesGrail's stock has slid as its Galleri MCED test faced a major trial setback. This piece breaks down what happened, wh...
If you’re wondering whether Eli Lilly stock still has room to run, you’re not alone. This guide outlines scenarios fo...
A budget deal would fund most Homeland Security programs, including TSA, while leaving ICE operations unfunded. The m...
A once-tiny energy startup sparked a rally after finally showing a profitable revenue stream through an acquired subs...
NuScale Power has sparked excitement around small modular reactors, but does the hype translate into real investing u...
Coal stocks moved higher as energy markets tensed. This piece breaks down why peabody energy other coal names jumped,...
Ford just revealed a bold $2 billion energy push designed to power AI data centers. This article breaks down what the...
A leading mega-cap health stock dropped last year but started the year with a powerful rebound. This guide breaks dow...
Robinhood just announced a substantial $1.5 billion buyback. In this analysis, we weigh the potential benefits agains...
Alaska Air Group stock surged this week as investors weighed fuel-cost pressures against resilient demand and discipl...
Dolly Parton sets Broadway marks a bold return after health setbacks, blending big dreams with big budgets. This arti...
Microsoft is staring down a tough start to the year. Is the slide a red flag or a rare chance to buy a tech titan wit...